Becton Dickinson Basic EPS 2010-2024 | BDX

Becton Dickinson annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
  • Becton Dickinson basic eps for the quarter ending September 30, 2024 was $1.45, a 314.29% increase year-over-year.
  • Becton Dickinson basic eps for the twelve months ending September 30, 2024 was $5.95, a 19.72% increase year-over-year.
  • Becton Dickinson annual basic eps for 2024 was $0.006B, a 19.92% increase from 2023.
  • Becton Dickinson annual basic eps for 2023 was $0.005B, a 16.19% decline from 2022.
  • Becton Dickinson annual basic eps for 2022 was $0.006B, a 14.31% decline from 2021.
Becton Dickinson Annual Basic EPS
2024 $5.96
2023 $4.97
2022 $5.93
2021 $6.92
2020 $2.75
2019 $4.01
2018 $0.62
2017 $4.70
2016 $4.59
2015 $3.43
2014 $6.13
2013 $6.63
2012 $5.69
2011 $5.75
2010 $5.62
2009 $5.12
Becton Dickinson Quarterly Basic EPS
2024-09-30 $1.45
2024-06-30 $1.68
2024-03-31 $1.85
2023-12-31 $0.97
2023-09-30 $0.35
2023-06-30 $1.37
2023-03-31 $1.54
2022-12-31 $1.71
2022-09-30 $0.94
2022-06-30 $1.18
2022-03-31 $1.51
2021-12-31 $2.30
2021-09-30 $0.86
2021-06-30 $1.73
2021-03-31 $0.95
2020-12-31 $3.38
2020-09-30 $0.36
2020-06-30 $0.98
2020-03-31 $0.53
2019-12-31 $0.88
2019-09-30 $0.46
2019-06-30 $1.53
2019-03-31 $-0.07
2018-12-31 $2.09
2018-09-30 $-0.51
2018-06-30 $2.08
2018-03-31 $-0.19
2017-12-31 $-0.76
2017-09-30 $1.20
2017-06-30 $-0.75
2017-03-31 $1.61
2016-12-31 $2.64
2016-09-30 $0.09
2016-06-30 $1.83
2016-03-31 $1.59
2015-12-31 $1.08
2015-09-30 $0.81
2015-06-30 $0.30
2015-03-31 $1.10
2014-12-31 $1.22
2014-09-30 $1.56
2014-06-30 $1.69
2014-03-31 $1.48
2013-12-31 $1.40
2013-09-30 $0.48
2013-06-30 $1.55
2013-03-31 $1.42
2012-12-31 $3.18
2012-09-30 $1.43
2012-06-30 $1.62
2012-03-31 $1.41
2011-12-31 $1.23
2011-09-30 $1.38
2011-06-30 $1.57
2011-03-31 $1.41
2010-12-31 $1.39
2010-09-30 $1.71
2010-06-30 $1.32
2010-03-31 $1.26
2009-12-31 $1.33
2009-09-30 $1.32
2009-06-30 $1.42
2009-03-31 $1.09
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.352B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36